National cancer screening program for gastric cancer in Korea: Nationwide treatment benefit and cost.
Yun Suhk SuhJoonki LeeHyeong Taek WooDongwook ShinSeong-Ho KongHyuk-Joon LeeAesun ShinHan-Kwang YangPublished in: Cancer (2020)
The screening group had significantly lower medical care expenses and showed a significantly better prognosis than the nonscreening group. On the basis of the GDP per capita, the NCSP for gastric cancer was cost-effective for treatment prognosis.